MxBiodevices' Angel Round

MxBiodevices raised a round of funding on February 10, 2014.

MxBiodevices commercializes an injectable nanoscaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU's) and other chronic wounds. MxBiodevices has exclusive rights to this injectable tissu…

Articles about MxBiodevices' Angel Round: